Investments addressing the women’s health gap could add years to life and life to years and potentially boost the global economy by $1 trillion annually by 2040.
There have been 38 reports of counterfeit semaglutide, the active ingredient in Ozempic and Wegovy, and 12 reports of counterfeit tirzepatide, the active ingredient in Mounjaro, according to an FDA database.